In this review:
Cohorts in microbiome research
Risks of malignancy in IBD
CD siblings exhibit dysbiosis
FMT for C. difficile infection
Fatty liver, diet and gut barrier dysfunction
Intestinal resection in CD; the POCER study
Safety of sofosbuvir-based HCV treatment
Evidence-based IBD management
Sofosbuvir regimens and genotypes
Treatment rates in HCV therapy
Telaprevir triple therapy
Early viral kinetics with sofosbuvir
Stool DNA testing for CRC
Sedation in endoscopy by an RN
Low-dose azathioprine and allopurinol in IBD
Accurate weight-based dosing of infliximab for IBD
Science blog: Basic science at DDW 2014
Please login below to download this issue (PDF)